Responses
Immune cell therapies and immune cell engineering
Original research
High-affinity CD16 integration into a CRISPR/Cas9-edited CD38 locus augments CD38-directed antitumor activity of primary human natural killer cells
Compose a Response to This Article
Other responses
No responses have been published for this article.
